Revenue (Annual)

Revenue: The sum of all revenue fields included for a company's operating activities.

Rockwell Medical, Inc. (RMTI) had Revenue of $101.49M for the most recently reported fiscal year, ending 2024-12-31.

Quarterly Annual

Figures for fiscal year ending 2024-12-31

Income Statement Financials
Revenue	$101.49M
Net Income	$-0.48M
Cost of Goods Sold	$84.00M
Gross Profit	$17.48M
Operating Expenses	$100.88M
Operating Income	$0.61M
Non-Operating Income/Expense	$-1.09M
Pre-Tax Income	$-0.48M
Normalized Pre-Tax Income	$-0.55M
Income after Taxes	$-0.48M
Income from Continuous Operations	$-0.48M
Consolidated Net Income/Loss	$-0.48M
Normalized Income after Taxes	$-0.55M
EBIT	$0.61M
EBITDA	$5.17M
Weighted-Average Shares Outstanding (Basic)	31.06M
Weighted-Average Shares Outstanding (Diluted)	31.06M
Earnings per Share (EPS) (Basic)	$-0.03
Earnings per Share (EPS) (Diluted)	$-0.03
Balance Sheet Financials
Current Assets	$37.03M
Property, Plant, and Equipment	$5.79M
Long-Term Assets	$22.18M
Total Assets	$59.21M
Current Liabilities	$14.09M
Long-Term Debt	$9.40M
Long-Term Liabilities	$12.53M
Total Liabilities	$26.62M
Common Equity	$32.59M
Tangible Shareholders Equity	$21.46M
Shareholders Equity	$32.59M
Common Shares Outstanding	34.06M
Cash Flow Statement Financials
Cash Flow from Operating Activities	$4.20M
Cash Flow from Investing Activities	$-4.87M
Cash Flow from Financial Activities	$7.35M
Beginning Cash	$8.98M
End Cash	$15.66M
Increase/Decrease in Cash	$6.68M
Stock-Based Compensation	$1.29M
Common Stock Dividends Paid	--
Preferred Stock Dividends Paid	--
Fundamental Metrics & Ratios
Current Ratio	2.63
Non-Performing Assets / Total Loans	--
Loan Loss Reserves / Non-Performing Loans	--
Debt to Capital Ratio	0.22
Debt to Equity Ratio	0.31
Gross Margin	17.23%
Operating Margin	0.60%
EBIT Margin	0.60%
EBITDA Margin	5.10%
Pre-Tax Profit Margin	-0.47%
Profit Margin	-0.47%
Free Cash Flow	$3.19M
Loss Ratio	--
Expense Ratio	--
Combined Ratio	--
Asset Turnover	1.71
Inventory Turnover	14.54
Receiveable Turnover	12.24
Days Sales in Receivables	29.82
Return on Equity	-1.47%
Return on Tangible Equity	-2.24%
Return on Assets	-0.81%
Return on Investments	-1.14%
Book Value Per Share	$0.96
Free Cash Flow per Share	$0.10
Operating Cash Flow per Share	$0.14

Data from Zacks Investment Research, Inc.